Leading Transgender Treatment Guidelines Under Fire in FTC Probe, Possible Uproar for Youth Care
The American Academy of Pediatrics' widely used transgender youth treatment guidelines are under investigation by the Federal Trade Commission, which alleges the organization received millions in funding from pharmaceutical companies that profit from hormone therapy treatments for trans youth. The probe could upend the guidelines, potentially harming the health and well-being of thousands of adolescents seeking medical care for gender dysphoria.
A probe by the Federal Trade Commission (FTC) has been launched against the Endocrine Society, a leading authority on transgender medical treatment, over allegations that it built influential treatment guidelines for transgender youth with ties to pharmaceutical companies. The organization's guidelines have been widely adopted by healthcare providers and policymakers. If found guilty of any wrongdoing, the FTC could potentially upend the existing treatment protocols. The outcome of this investigation has significant implications for the care and treatment of transgender youth in the US.
